Boomerang Medical

Boomerang Medical is a developer of bioelectronic medicine technology designed to advance the treatment of autoimmune diseases
2021
9
California, United States

Innovation

Industry Problem

Inflammatory Bowel Disease (IBD) is one of the most debilitating autoimmune diseases

R&D Focus

Bioelectronic medicine technology

Innovative Solution

Boomerang Medical is developing the treatment of autoimmune diseases by developing a bioelectric neuromodulation technology, which has been granted Breakthrough Device Designation by the FDA(Food and Drug Administration) for the treatment of Crohn’s disease and ulcerative colitis

Solution Effectiveness

Boomerang Medical is focusing on neuromodulation. Through bioelectronic medicine, they harness the body’s physiology to manage inflammation and immune response

Investment Funding

Last Funding Stage

Series A

Total Funding Amount

$18M

Last Funding Amount

$15M

Last Funding Date

Nov 1, 2022

Startup Stage

Early-Stage

Lead Investors

Hatteras Venture Partners, Fogarty Innovation, Arboretum Ventures

People

Founders

CEO

Products

Demo Product or Complete Product?

Development

Awards and Recognitions

Awards

Promising Up-and-Comer by the Crohn’s & Colitis Foundation2023

Media Apperance

Medical Product Outsourcing, Neurotech Reports, Biospace